Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Mifepristone"" wg kryterium: Temat


Tytuł :
Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
Autorzy :
Kerestes C; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States. Electronic address: .
Murayama S; John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Tyson J; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Natavio M; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Seamon E; John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Raidoo S; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Lacar L; John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Bowen E; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Soon R; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Platais I; Gynuity Health Projects, New York, NY, United States.
Kaneshiro B; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Stowers P; Department of Obstetrics, Gynecology, and Women's Health, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI, United States.
Pokaż więcej
Źródło :
Contraception [Contraception] 2021 Jul; Vol. 104 (1), pp. 49-53. Date of Electronic Publication: 2021 Mar 28.
Typ publikacji :
Journal Article
MeSH Terms :
Abortifacient Agents*
Mifepristone*
Misoprostol*
Abortion, Induced/*methods
COVID-19/*prevention & control
Telemedicine/*methods
Abortion, Induced/adverse effects ; Adult ; Aftercare/methods ; Aftercare/trends ; Female ; Hawaii ; Humans ; Outcome Assessment, Health Care ; Pregnancy ; Retrospective Studies ; Ultrasonography, Prenatal
Czasopismo naukowe
Tytuł :
Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
Autorzy :
Okeke Ogwulu CB; Health Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Williams EV; Health Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Chu JJ; Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Devall AJ; Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Beeson LE; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Hardy P; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Cheed V; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Yongzhong S; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Jones LL; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
La Fontaine Papadopoulos JH; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Bender-Atik R; The Miscarriage Association, Wakefield, UK.
Brewin J; Tommy's Charity, London, UK.
Hinshaw K; Sunderland Royal Hospital, South Tyneside & Sunderland NHS Foundation Trust, Sunderland, UK.
Choudhary M; Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Ahmed A; Sunderland Royal Hospital, South Tyneside & Sunderland NHS Foundation Trust, Sunderland, UK.
Naftalin J; University College Hospital, University College London Hospitals NHS Foundation Trust, London, UK.
Nunes N; West Middlesex University Hospital, Chelsea and Westminster Hospital NHS Foundation Trust, Isleworth, UK.
Oliver A; St Michael's Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Izzat F; University Hospital Coventry, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Bhatia K; Burnley General Hospital, East Lancashire Hospitals NHS Trust, Burnley, UK.
Hassan I; Birmingham Women's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Jeve Y; Birmingham Women's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Hamilton J; Guy's and St Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Debs S; Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Bottomley C; University College Hospital, University College London Hospitals NHS Foundation Trust, London, UK.
Ross J; Kings College Hospital, King's College Hospital NHS Foundation Trust, London, UK.
Watkins L; Liverpool Women's Hospital, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
Underwood M; Princess Royal Hospital, Shrewsbury and Telford Hospital NHS Trust, Telford, UK.
Cheong Y; Department of Reproductive Medicine, University of Southampton, Southampton, UK.
Kumar CS; NHS Greater Glasgow and Clyde, Glasgow, UK.
Gupta P; Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Small R; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
Pringle S; NHS Greater Glasgow and Clyde, Glasgow, UK.
Hodge FS; Singleton Hospital, Swansea Bay University Health Board, Swansea, UK.
Shahid A; Barts Health NHS Trust, The Royal London Hospital, London, UK.
Horne AW; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Quenby S; The Biomedical Research Unit in Reproductive Health, University of Warwick, Warwick, UK.
Gallos ID; Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Coomarasamy A; Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Roberts TE; Health Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2021 Aug; Vol. 128 (9), pp. 1534-1545. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Abortifacient Agents/*administration & dosage
Abortion, Missed/*drug therapy
Mifepristone/*administration & dosage
Misoprostol/*administration & dosage
Abortifacient Agents/economics ; Abortion, Missed/economics ; Adolescent ; Adult ; Cost-Benefit Analysis ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Mifepristone/economics ; Misoprostol/economics ; Pregnancy ; Young Adult
Czasopismo naukowe
Tytuł :
The Supreme Court's Abortion Exceptionalism - Judicial Deference, Medical Science, and Mifepristone Access.
Autorzy :
Fox D; From the University of San Diego School of Law (E.C.), and the Center for Health Law Policy and Bioethics, University of San Diego School of Law (D.F.), San Diego, CA.
Cole E; From the University of San Diego School of Law (E.C.), and the Center for Health Law Policy and Bioethics, University of San Diego School of Law (D.F.), San Diego, CA.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Jun 17; Vol. 384 (24), pp. e94. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article
MeSH Terms :
Abortifacient Agents, Steroidal*
Government Regulation*
Mifepristone*
Supreme Court Decisions*
Abortion, Legal/*legislation & jurisprudence
Health Services Accessibility/*legislation & jurisprudence
United States Food and Drug Administration/*legislation & jurisprudence
Female ; Humans ; Politics ; Pregnancy ; United States
Czasopismo naukowe
Tytuł :
Cardiac arrest and resuscitation activates the hypothalamic-pituitary-adrenal axis and results in severe immunosuppression.
Autorzy :
Zhao Q; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Shen Y; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.; Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, China.
Li R; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Wu J; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Lyu J; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.; Department of Emergency Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Jiang M; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.; Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, China.
Lu L; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Zhu M; Department of Immunology, Duke University Medical Center, Durham, NC, USA.
Wang W; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Wang Z; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Liu Q; Department of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, USA.
Hoffmann U; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Karhausen J; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Sheng H; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Zhang W; Department of Immunology, Duke University Medical Center, Durham, NC, USA.
Yang W; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Pokaż więcej
Źródło :
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2021 May; Vol. 41 (5), pp. 1091-1102. Date of Electronic Publication: 2020 Aug 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiopulmonary Resuscitation/*adverse effects
Heart Arrest/*therapy
Hypothalamo-Hypophyseal System/*drug effects
Mifepristone/*pharmacology
Pituitary-Adrenal System/*drug effects
Animals ; Brain/metabolism ; Brain/physiopathology ; Cardiopulmonary Resuscitation/methods ; Case-Control Studies ; Cytokines/metabolism ; Glucocorticoids/administration & dosage ; Glucocorticoids/pharmacology ; Heart Arrest/complications ; Heart Arrest/pathology ; Homeostasis/drug effects ; Hormone Antagonists/administration & dosage ; Hormone Antagonists/pharmacology ; Hypothalamo-Hypophyseal System/immunology ; Hypothalamo-Hypophyseal System/metabolism ; Hypothalamo-Hypophyseal System/physiopathology ; Immunosuppression/adverse effects ; Male ; Mice ; Mice, Inbred C57BL ; Mifepristone/administration & dosage ; Models, Animal ; Pituitary-Adrenal System/immunology ; Pituitary-Adrenal System/metabolism ; Pituitary-Adrenal System/physiopathology ; Prognosis ; Reperfusion Injury
Czasopismo naukowe
Tytuł :
Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
Autorzy :
Allanson ER; Division of Obstetrics and Gynaecology, University of Western Australia, Perth, the Institute for Health Research, University of Notre Dame, Fremantle, King Edward Memorial Hospital, Perth, Western Australia, and the Office of the Chief Nurse and Midwife, Department of Health, Northern Territory Government, Darwin, Northern Territory, Australia.
Copson S
Spilsbury K
Criddle S
Jennings B
Doherty DA
Wong AM
Dickinson JE
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2021 May 01; Vol. 137 (5), pp. 801-809.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Abortifacient Agents*
Abortion, Induced*
Mifepristone*
Misoprostol*
Adult ; Double-Blind Method ; Female ; Fetal Death ; Humans ; Pregnancy ; Pregnancy Trimester, Second ; Prospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Mifepristone and Misoprostol for Early Pregnancy Loss and Medication Abortion.
Autorzy :
Macnaughton H; Tufts University Family Medicine Residency at Cambridge Health Alliance, Malden, MA, USA.
Nothnagle M; Natividad Family Medicine Residency, Salinas, CA, USA.
Early J; Tufts University Family Medicine Residency at Cambridge Health Alliance, Malden, MA, USA.
Pokaż więcej
Źródło :
American family physician [Am Fam Physician] 2021 Apr 15; Vol. 103 (8), pp. 473-480.
Typ publikacji :
Journal Article
MeSH Terms :
Abortifacient Agents, Nonsteroidal/*administration & dosage
Mifepristone/*administration & dosage
Misoprostol/*administration & dosage
Abortifacient Agents, Nonsteroidal/adverse effects ; Abortion, Induced ; Abortion, Spontaneous ; Female ; Humans ; Mifepristone/adverse effects ; Misoprostol/adverse effects ; Pregnancy ; Prenatal Care
Czasopismo naukowe
Tytuł :
Cochrane Review Summaries-April 2021.
Autorzy :
Cohen M; Megan Cohen and Alison Edelman are from the Division of Complex Family Planning, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon. Federica Bellussi is from the Department of Obstetrics and Gynecology, University of Bologna, Bologna, Italy. Vincenzo Berghella is from the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, Pennsylvania. David M. Haas is from the Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana; email: .
Edelman A
Bellussi F
Berghella V
Haas DM
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2021 Apr 01; Vol. 137 (4), pp. 747-749.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Abortifacient Agents, Nonsteroidal*
Abortion, Induced*
Mifepristone*
Self Administration*
Female ; Humans ; Pregnancy ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
A Retrospective Cost-Effectiveness Analysis of Mifepristone-Misoprostol Medical Abortions in the First Year at the Regina General Hospital.
Autorzy :
Hunter C; Department of Family Medicine, University of Saskatchewan, Saskatoon, SK.
Jensen J; Department of Family Medicine, University of Saskatchewan, Saskatoon, SK.
Imeah B; Research Department, Saskatchewan Health Authority, Regina, SK.
McCarron M; Research Department, Saskatchewan Health Authority, Regina, SK.
Clark M; Department of Family Medicine, University of Saskatchewan, Saskatoon, SK; Women's Health Centre, Regina General Hospital, Saskatchewan Health Authority, Regina, SK. Electronic address: .
Pokaż więcej
Źródło :
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [J Obstet Gynaecol Can] 2021 Feb; Vol. 43 (2), pp. 211-218. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji :
Journal Article
MeSH Terms :
Abortion, Induced/*economics
Mifepristone/*economics
Misoprostol/*economics
Abortion, Induced/statistics & numerical data ; Cost-Benefit Analysis ; Female ; Hospitals, General ; Humans ; Mifepristone/therapeutic use ; Misoprostol/therapeutic use ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The efficacy and safety of Xuefu Zhuyu Decoction combined Mifepristone in the treatment of Uterine leiomyoma: A protocol systematic review and meta-analysis.
Autorzy :
Shi S; Department of Basic Medicine, College of Chengdu University of Traditional Chinese Medicine.
Ye Q; Department of Basic Medicine, College of Chengdu University of Traditional Chinese Medicine.
Yu C; Department of Basic Medicine, College of Chengdu University of Traditional Chinese Medicine.
Peng F; Department of West China School of Pharmacy, College of Sichuan University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jan 22; Vol. 100 (3), pp. e24306.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Protocols*
Drugs, Chinese Herbal/*therapeutic use
Leiomyoma/*drug therapy
Mifepristone/*therapeutic use
Drugs, Chinese Herbal/adverse effects ; Hormone Antagonists/adverse effects ; Hormone Antagonists/therapeutic use ; Humans ; Leiomyoma/physiopathology ; Meta-Analysis as Topic ; Mifepristone/adverse effects ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł :
Effects of RU486 treatment after single prolonged stress depend on the post-stress interval.
Autorzy :
Ding J; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands; PTSD Lab, Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, PR China.
Chen X; PTSD Lab, Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, PR China.
da Silva MS; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands.
Lingeman J; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands.
Han F; PTSD Lab, Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, PR China. Electronic address: .
Meijer OC; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden University, Leiden, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Molecular and cellular neurosciences [Mol Cell Neurosci] 2020 Oct; Vol. 108, pp. 103541. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hormone Antagonists/*therapeutic use
Mifepristone/*therapeutic use
Stress Disorders, Post-Traumatic/*drug therapy
Animals ; Brain/drug effects ; Brain/metabolism ; DNA Methylation ; Drug Administration Schedule ; Hormone Antagonists/administration & dosage ; Hormone Antagonists/pharmacology ; Male ; Mifepristone/administration & dosage ; Mifepristone/pharmacology ; Rats ; Rats, Wistar ; Receptors, Glucocorticoid/antagonists & inhibitors ; Tacrolimus Binding Proteins/genetics ; Tacrolimus Binding Proteins/metabolism
Czasopismo naukowe
Tytuł :
Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
Autorzy :
Ferguson I; IWK Health Centre, Halifax, NS. Electronic address: .
Scott H; IWK Health Centre, Halifax, NS.
Pokaż więcej
Źródło :
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [J Obstet Gynaecol Can] 2020 Dec; Vol. 42 (12), pp. 1532-1542.e2. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Abortion, Induced*
Patient Acceptance of Health Care*
Abortifacient Agents/*therapeutic use
Abortifacient Agents, Nonsteroidal/*adverse effects
Mifepristone/*therapeutic use
Misoprostol/*therapeutic use
Abortifacient Agents/adverse effects ; Developing Countries ; Female ; Humans ; Mifepristone/adverse effects ; Misoprostol/adverse effects ; Pregnancy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
Autorzy :
Berkley HH; Department of Obstetrics & Gynecology at Naval Medical Center San Diego, San Diego, California; and the Uniformed Services University, Bethesda, Maryland.
Greene HL
Wittenberger MD
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2020 Oct; Vol. 136 (4), pp. 774-781.
Typ publikacji :
Journal Article
MeSH Terms :
Abortion, Incomplete*/chemically induced
Abortion, Incomplete*/economics
Abortion, Incomplete*/surgery
Abortion, Induced*/adverse effects
Abortion, Induced*/economics
Abortion, Induced*/methods
Drug Therapy, Combination*/economics
Drug Therapy, Combination*/methods
Mifepristone*/administration & dosage
Mifepristone*/economics
Misoprostol*/administration & dosage
Misoprostol*/economics
Abortifacient Agents/administration & dosage ; Abortifacient Agents/economics ; Cost-Benefit Analysis ; Dilatation and Curettage/economics ; Dilatation and Curettage/methods ; Female ; Humans ; Monte Carlo Method ; Practice Patterns, Physicians' ; Pregnancy
Czasopismo naukowe
Tytuł :
Targeting progesterone signaling prevents metastatic ovarian cancer.
Autorzy :
Kim O; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202.
Park EY; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202.
Kwon SY; Department of Pathology, School of Medicine, Keimyung University, 41931 Daegu, Republic of Korea.
Shin S; Department of Obstetrics and Gynecology, School of Medicine, Keimyung University, 41931 Daegu, Republic of Korea.
Emerson RE; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202.
Shin YH; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202.
DeMayo FJ; Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.
Lydon JP; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX 77030.
Coffey DM; Department of Pathology and Genomic Medicine, Houston Methodist and Weill Cornell Medical College, Houston, TX 77030.
Hawkins SM; Department of Obstetrics and Gynecology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202.
Quilliam LA; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202.
Cheon DJ; Department of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, NY 12208.
Fernández FM; School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332.
Nephew KP; Medical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47405.
Karpf AR; Eppley Institute for Cancer Research, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198.
Widschwendter M; Department of Women's Cancer, Institute for Women's Health, University College London, WC1E 6AU London, United Kingdom.; Research Institute for Biomedical Aging Research, Universität Innsbruck, 6020 Innsbruck, Austria.; European Translational Oncology Prevention and Screening (EUTOPS) Institute, Universität Innsbruck, 6060 Hall in Tirol, Austria.
Sood AK; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.; Department of Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Bast RC Jr; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160.
Miller KD; Department of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202 .
Cho CH; Department of Obstetrics and Gynecology, School of Medicine, Keimyung University, 41931 Daegu, Republic of Korea; .
Kim J; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202; .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Dec 15; Vol. 117 (50), pp. 31993-32004. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
BRCA1 Protein/*genetics
Cystadenocarcinoma, Serous/*prevention & control
Mifepristone/*pharmacology
Ovarian Neoplasms/*prevention & control
Progesterone/*antagonists & inhibitors
Adult ; Animals ; Breast/pathology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Breast Neoplasms/prevention & control ; Cystadenocarcinoma, Serous/chemistry ; Cystadenocarcinoma, Serous/genetics ; Cystadenocarcinoma, Serous/pathology ; Disease Models, Animal ; Estradiol/administration & dosage ; Female ; Humans ; Mice ; Middle Aged ; Mifepristone/therapeutic use ; Mutation ; Neoplasms, Experimental/chemically induced ; Neoplasms, Experimental/genetics ; Neoplasms, Experimental/pathology ; Neoplasms, Experimental/prevention & control ; Ovarian Neoplasms/chemically induced ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Ovary/pathology ; Ovary/surgery ; Progesterone/administration & dosage ; Progesterone/metabolism ; Receptors, Progesterone/genetics ; Receptors, Progesterone/metabolism ; Salpingo-oophorectomy ; Signal Transduction/drug effects ; Signal Transduction/genetics
Czasopismo naukowe
Tytuł :
Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life.
Autorzy :
Check JH; Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Cooper Medical School of Rowan University, Camden, NJ, U.S.A. .; Cooper Institute for Reproductive Hormonal Disorders, P.C., Mt. Laurel, NJ, U.S.A.; .
Check D; Cooper Institute for Reproductive Hormonal Disorders, P.C., Mt. Laurel, NJ, U.S.A.
Srivastava MD; Department of Medicine, Division of Allergy and Immunology, State University of New York (SUNY) at Buffalo, Buffalo, NY, U.S.A.
Poretta T; Kennedy Medical Campus, Sewell, NJ, U.S.A.
Aikins JK; Division of Gynecologic Oncology, Cooper Medical School of Rowan University, Camden, NJ, U.S.A.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Dec; Vol. 40 (12), pp. 6997-7001. Date of Electronic Publication: 2020 Dec 07.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Analgesics, Opioid/*therapeutic use
Hormone Antagonists/*therapeutic use
Mifepristone/*therapeutic use
Morphine/*therapeutic use
Pancreatic Neoplasms/*drug therapy
Quality of Life/*psychology
Analgesics, Opioid/pharmacology ; Hormone Antagonists/pharmacology ; Humans ; Male ; Middle Aged ; Mifepristone/pharmacology ; Morphine/pharmacology ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Survival Analysis
Czasopismo naukowe
Tytuł :
Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.
Autorzy :
Chinery L; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Allaouidine C; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Tomazzini A; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Larson M; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Gülmezoglu AM; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland. .
Pokaż więcej
Źródło :
Reproductive health [Reprod Health] 2020 Nov 04; Vol. 17 (1), pp. 171. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article
MeSH Terms :
Abortion, Induced/*statistics & numerical data
Mifepristone/*economics
Misoprostol/*economics
Abortion, Induced/economics ; Abortion, Induced/methods ; Bangladesh ; China ; Cost-Benefit Analysis ; Female ; Humans ; India ; Mifepristone/therapeutic use ; Misoprostol/therapeutic use ; Pregnancy
Czasopismo naukowe
Tytuł :
Mifepristone Decreases Chronic Voluntary Ethanol Consumption in Rhesus Macaques.
Autorzy :
Jimenez VA; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.).
Walter NAR; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.).
Shnitko TA; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.).
Newman N; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.).
Diem K; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.).
Vanderhooft L; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.).
Hunt H; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.).
Grant KA; Division of Neuroscience, Oregon National Primate Research Center, Hillsboro, Oregon (V.A.J., N.A.R.W., T.A.S., N.N., K.D., L.V., K.A.G.); Corcept Therapeutics, Menlo Park, California (H.H.); and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon (K.A.G.) .
Pokaż więcej
Źródło :
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2020 Nov; Vol. 375 (2), pp. 258-267. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Alcohol Drinking/*drug therapy
Mifepristone/*pharmacology
Animals ; Drinking/drug effects ; Macaca mulatta ; Male ; Mifepristone/therapeutic use ; Self Administration
Czasopismo naukowe
Tytuł :
Simultaneous compared to interval administration of mifepristone and misoprostol for medical abortion up to 10 weeks' gestation: a systematic review with meta-analyses.
Autorzy :
Schmidt-Hansen M; National Guideline Alliance, Royal College of Obstetricians and Gynaecologists, London, UK .
Lord J; Department of Gynaecology, Royal Cornwall Hospitals NHS Trust, Truro, UK.
Hasler E; National Guideline Alliance, Royal College of Obstetricians and Gynaecologists, London, UK.
Cameron S; Sexual and Reproductive Health Services, NHS Lothian, Edinburgh, UK.
Pokaż więcej
Źródło :
BMJ sexual & reproductive health [BMJ Sex Reprod Health] 2020 Oct; Vol. 46 (4), pp. 270-278. Date of Electronic Publication: 2020 Feb 20.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Gestational Age*
Abortion, Induced/*standards
Mifepristone/*administration & dosage
Misoprostol/*administration & dosage
Abortifacient Agents, Steroidal/administration & dosage ; Abortifacient Agents, Steroidal/therapeutic use ; Abortion, Induced/methods ; Abortion, Induced/trends ; Female ; Humans ; Mifepristone/therapeutic use ; Misoprostol/therapeutic use ; Pregnancy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies